Visit our website

Stocks & Gains

Home Todays Alert Contact Us About Us

 

Safety Shot, Inc.

NASDAQ: SHOT

Last Price: $1.38


Good Evening Reader,


Safety Shot, Inc. (SHOT) Has A Float Under 40M Shares That is Approaching A Big Support Level! The Company Has Developed A First-Of-Its-Kind Beverage And Has Partnered With The Nelk Boys.


--


Free up your schedule and make sure you've got this groundbreaking, Enhancing Recovery, Boosting Clarity, backed by scientific evidence, beverage company on your radar before the stock market opens.


--

About Safety Shot, Inc.

In summary, SHOT has crafted an innovative beverage designed to alleviate the effects of alcohol swiftly, bolstering mental clarity while reducing blood alcohol content. By leveraging scientifically proven ingredients, Safety Shot optimizes metabolic pathways crucial for alcohol breakdown. Its formulation features a tailored blend of natural vitamins, minerals, and nootropics, facilitating rapid recovery and rehydration. Available for retail purchase since December 2023, Safety Shot is formulated to prevent blood alcohol accumulation. Notably, this beverage boasts 28 active ingredients, all classified as Generally Regarded as Safe (GRAS).


Most Recent News (Dated 04/09/24):


"Nelk Boys to Partner With Safety Shot to Bring the Recovery & Wellness Drink to Fans and Followers".


See Full Press Release: Here


●The Nelk Boys, a widely followed YouTube and social media entertainment groups, join Safety Shot as brand ambassadors.

●With over 10 million subscribers across their channels on YouTube, more than 1.6 billion views, and 4.3 million followers on Instagram, the Nelk Boys are some of the most recognizable internet personalities in North America.

●Safety Shot — Extend the night, enhance the morning.



Most Notable Catalysts for SHOT: 


● The Safety Shot Beverage was launched in December 2023 on our website and Amazon, with plans to expand into Big Box stores by Q2 2024.

● Photocil, launched commercially in India in Q3 2022, treats vitiligo and psoriasis using safe, at-home phototherapy with natural sunlight.

● Photocil, an FDA-approved topical cream, blocks harmful radiation while allowing therapeutic UV radiation.

● Photocil will be relaunched in the US in Q4 2024, with FDA-approved labeling and ingredients.

● JW-700, under licensing abroad and in development for US launch, boosts minoxidil effectiveness topically.

● JW-700's clinical studies and formulation are ongoing, aiming for a US launch in Q4 2024.

● SS-100's formulation design will follow Safety Shot Beverage's clinical trial results, aiming for FDA approval.

● SS-100 targets acute alcohol poisoning as a rare disease, seeking Orphan Drug Designation from the FDA.

● The company holds five patents, including ones for the Safety Shot Beverage's composition.

● Provisional patents cover CBD formulations and uses, sunscreen, and oronasal CBD treatments.

● Safety Shot collaborates with Launch 33 Brands to expand its presence in Southern California's market.

● Safety Shot licenses Jupiter Wellness assets to Elite Health Partners Inc., who plans an IPO by Q3 2024.

● Elite Health's IPO will include Safety Shot's Jupiter Wellness assets, benefitting Safety Shot's shareholders.



Chart Overview: Click to Zoom in on Chart

Currently, SHOT is sitting in a big support zone. Keep an eye for a potential bounce from these levels with the first resistance at $1.75. A significant breakout might occur if it surpasses that level. Get SHOT on your radar today!

--

Sincerely,

Stocks & Gains

Reminder: Please keep in mind that investing involves risks, and you should always be mindful of protecting your capital. We encourage you to develop your own personal trading rules and consult with your financial, tax, and legal advisors before making any investment decisions. Remember to never invest more than you can afford to lose. It's crucial to make informed decisions and have a solid understanding of your risk tolerance. Protecting your capital should always be a top priority.

 

Disclaimer: All content provided by Stocks&Gains Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. Stocks&Gains Report are not liable for any losses or damages incurred as a result of using this information. Stocks&Gains is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by Stocks&Gains Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by Stocks&Gains Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. Stocks&Gains Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by Stocks&Gains Report. Stocks&Gains Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by Stocks&Gains Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. Stocks&Gains is not a fiduciary by virtue of any person's use of or access to this content. We have been compensated one thousand dollars by bank wire transfer for the distribution of this advertisement about SHOT dated 5/5/24-5/7/24. We hold no stocks or bonds in this company.


Privacy Policy | Disclaimer | Contact Us

Copyright © 2023 Stockandgains.com - All Rights Reserved.